GlassScriptPhysician profile
Karen Cheek
NPI 1316052442
$1,072.13
in general payments reported to CMS, 2019-2025
17 companies · $419 in 2025
The $419 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $201 · 2022: $96.12 · 2023: $101 · 2024: $255 · 2025: $419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $726 · Education: $48.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $726.12 |
| Education | $48.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $268.94 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $231.86 | 2024-2025 | Caplyta |
| Astrazeneca Pharmaceuticals LP | $103.29 | 2021-2025 | |
| Lilly USA, LLC | $92.68 | 2021-2025 | Mounjaro, Jardiance, Trulicity |
| Otsuka America Pharmaceutical, INC. | $82.79 | 2023-2025 | Rexulti, Nuedexta |
| Vanda Pharmaceuticals INC. | $66.63 | 2025 | Fanapt, Hetlioz |
| Merck Sharp & Dohme LLC | $35.08 | 2021-2022 | |
| Dexcom, INC. | $34.97 | 2021-2023 | Dexcom G6 Transmitter |
| Kyowa Kirin, INC. | $22.05 | 2025 | |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $20.20 | 2025 | Spravato |
| Biohaven Pharmaceuticals, INC. | $19.09 | 2021 | |
| Pfizer INC. | $17.30 | 2024 | |
| Phadia US INC. | $17.00 | 2025 | Immunocap |
| Astellas Pharma US INC | $14.44 | 2023 | Veozah |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $13.66 | 2022 | |
| Sumitomo Pharma America, INC. | $11.15 | 2023 | Aptiom |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Cheek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.